Hepatobiliary neoplasm

Search with Google Search with Bing
Information
Disease name
Hepatobiliary neoplasm
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04501913 Active, not recruiting Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes December 24, 2019 December 24, 2024
NCT06049836 Completed N/A Holographic Augmented Reality Versus Screen Visualisation of 3D Rendering Models for the Pre-operative Evaluation and Planning of Liver Resections October 15, 2023 February 1, 2024
NCT01135849 Completed B-Receptor Signaling in Cardiomyopathy November 2008 October 2010
NCT04959630 Completed N/A Immersive Virtual Reality Environment for Complex Cognitive Skills Curricular Training in Liver Surgery September 1, 2020 June 15, 2021
NCT04642664 Completed Phase 2 Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer December 1, 2018 January 1, 2021
NCT04010071 Recruiting Phase 2 Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors May 1, 2020 June 30, 2024
NCT00767234 Terminated Permission to Collect Blood Over Time for Research August 2008 October 2011
NCT01151761 Terminated Phase 2 Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation January 2011 July 2012
NCT01020812 Terminated Phase 1/Phase 2 Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma September 2009 March 2014
NCT04709445 Unknown status N/A Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses March 1, 2020 December 2021
NCT03818997 Withdrawn Phase 2 Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer December 2019 April 2022